Who uses us

Workflow

Tumour neoantigen identification software tools | Whole-genome sequencing data analysis

Tumour neoantigen identification software tools | Whole-genome sequencing data analysis Cancer immunotherapy has gained significant momentum from recent clinical successes of checkpoint blockade inhibition. Massively parallel sequence analysis suggests a connection between mutational load and response to this class of therapy. Methods to identify which tumor-specific mutant peptides (neoantigens) can elicit anti-tumor T cell immunity are needed to improve predictions of checkpoint therapy response and to identify targets for vaccines and adoptive T cell therapies.
1 - 7 of 15 results
tune Filters / Sort by
Sort by:
Filter by:
Desktop filters Mobile filters

Want to access data filter options?

Get started
1 - 7 of 15 results
Want to access more resources?